Články se zplnomocněním k veřejnému přístupu - "Jose C. Nicolau" or "Jose Nicolau" or "Jose Carlos Nicolau" or "Nicolau JC" or Nicolau JDalší informace
Nedostupné nikde: 8
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo …
PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ...
The Lancet 390 (10105), 1833-1842, 2017
Zplnomocnění: US National Institutes of Health
The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA• CER) trial: study design and rationale
TRA The, CER Executive, S Committees
American Heart Journal 158 (3), 327-334. e4, 2009
Zplnomocnění: US National Institutes of Health
Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed …
JC Nicolau, DL Bhatt, MT Roe, Y Lokhnygina, B Neely, R Corbalán, ...
American heart journal 170 (4), 683-694. e3, 2015
Zplnomocnění: US National Institutes of Health
High-sensitivity troponin I in stable patients with atherosclerotic disease in the TRA 2° P-TIMI 50 trial
A Eisen, MP Bonaca, P Jarolim, BM Scirica, HD White, M Tendera, ...
Clinical chemistry 63 (1), 307-315, 2017
Zplnomocnění: US Department of Agriculture
Low‐power laser irradiation decreases lipid droplet accumulation in the parotid glands of diabetic rats
JR de Castro, EMN de Souza, YJ Park, L de Campos, S Cha, ...
Journal of Biophotonics 11 (4), e201700179, 2018
Zplnomocnění: US National Institutes of Health
The impact of sonothrombolysis on left ventricular diastolic function and left atrial mechanics preventing left atrial remodeling in patients with ST elevation acute myocardial …
HP Chiang, MOD Aguiar, BG Tavares, VEE Rosa, SB Gomes, ...
Journal of the American Society of Echocardiography 36 (5), 504-513, 2023
Zplnomocnění: Fundação de Amparo à Pesquisa do Estado de São Paulo
Comparison between two different local hemostatic methods for dental extractions in patients on dual antiplatelet therapy: a within-person, single-blind, randomized study
B Guardieiro, MA Santos-Paul, RH de Mendonça Furtado, T Dalçóquio, ...
Journal of Evidence-Based Dental Practice 23 (3), 101863, 2023
Zplnomocnění: Fundação de Amparo à Pesquisa do Estado de São Paulo
Comparing plasma and skin imprint metabolic profiles in COVID-19 diagnosis and severity assessment
J Delafiori, RF Siciliano, AN de Oliveira, JC Nicolau, GM Sales, ...
Journal of Molecular Medicine 102 (2), 183-195, 2024
Zplnomocnění: Fundação de Amparo à Pesquisa do Estado de São Paulo
Dostupné někde: 69
Antiinflammatory therapy with canakinumab for atherosclerotic disease
PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...
New England journal of medicine 377 (12), 1119-1131, 2017
Zplnomocnění: US National Institutes of Health
Dapagliflozin in patients with heart failure and reduced ejection fraction
JJV McMurray, SD Solomon, SE Inzucchi, L Køber, MN Kosiborod, ...
New England Journal of Medicine 381 (21), 1995-2008, 2019
Zplnomocnění: German Research Foundation
Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19
ATTACC, ACTIV-4a, and REMAP-CAP Investigators
New England Journal of Medicine 385 (9), 790-802, 2021
Zplnomocnění: US National Institutes of Health, National Health and Medical Research …
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ...
The Lancet 391 (10117), 219-229, 2018
Zplnomocnění: American Heart Association
Myocardial viability and survival in ischemic left ventricular dysfunction
RO Bonow, G Maurer, KL Lee, TA Holly, PF Binkley, P Desvigne-Nickens, ...
New England Journal of Medicine 364 (17), 1617-1625, 2011
Zplnomocnění: US National Institutes of Health
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled …
PM Ridker, JG MacFadyen, BM Everett, P Libby, T Thuren, RJ Glynn, ...
The Lancet 391 (10118), 319-328, 2018
Zplnomocnění: US National Institutes of Health
Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes
MC Petrie, S Verma, KF Docherty, SE Inzucchi, I Anand, J Bělohlávek, ...
Jama 323 (14), 1353-1368, 2020
Zplnomocnění: US National Institutes of Health, British Heart Foundation
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ...
The Lancet 391 (10117), 205-218, 2018
Zplnomocnění: US Department of Veterans Affairs, American Heart Association
Effects of dapagliflozin on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction: results from the DAPA-HF trial
MN Kosiborod, PS Jhund, KF Docherty, M Diez, MC Petrie, S Verma, ...
Circulation 141 (2), 90-99, 2020
Zplnomocnění: US National Institutes of Health, British Heart Foundation
Dapagliflozin and cardiovascular outcomes in patients with type 2 diabetes mellitus and previous myocardial infarction: subanalysis from the DECLARE-TIMI 58 Trial
RHM Furtado, MP Bonaca, I Raz, TA Zelniker, O Mosenzon, A Cahn, ...
Circulation 139 (22), 2516-2527, 2019
Zplnomocnění: German Research Foundation
Ticagrelor in patients with stable coronary disease and diabetes
PG Steg, DL Bhatt, T Simon, K Fox, SR Mehta, RA Harrington, C Held, ...
New England journal of medicine 381 (14), 1309-1320, 2019
Zplnomocnění: Netherlands Organisation for Health Research and Development, Agence …
A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left …
JJV McMurray, DL DeMets, SE Inzucchi, L Køber, MN Kosiborod, ...
European journal of heart failure 21 (5), 665-675, 2019
Zplnomocnění: US National Institutes of Health
Informace o publikování a financování jsou automaticky vybírány počítačovým programem